| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3873abaff397acbfffa1595a12cfef41 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6895 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
1997-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd5f2283ccddab7471ae449d0725931d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d83d887ec9b5e01f0c7b23ba9c008485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f6bf9c26275d6577295a9d4ff760626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f89320e6c16338e3517fe05d21ec6e22 |
| publicationDate |
1999-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2218446-A1 |
| titleOfInvention |
New candida albicans kre9 and uses thereof |
| abstract |
The present invention relates to an isolated DNA which codes for a gene essential for cell wall glucan synthesis of Candida albicans, wherein the gene is referred to as CaKRE9, wherein the sequence of the DNA is as set forth in Fig. 1. The present invention relates antifungal in vitro and in vivo screening assays for identifying a compound which inhibit the synthesis, assembly and/or regulation of .beta.1,6-glucans. There is also disclosed an in vitro method for the diagnosis of diseases caused by fungal infection in a patient. |
| priorityDate |
1997-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |